03347 泰格醫藥
公司資料 - 財務比率
杭州泰格醫藥科技股份有限公司 股票編號: 03347
HANGZHOU TIGERMED CONSULTING CO., LTD. 集團網址: http://www.tigermedgrp.com
盈利能力分析
2023/12 2022/12 2021/12 2020/12 2019/12
資產回報率 (%)7.095%7.877%13.315%12.937%13.842%
股東資金回報率 (%)9.959%10.663%16.769%17.169%23.781%
資本運用回報率 (%)7.934%8.501%13.499%9.535%14.615%
 
邊際利潤分析
毛利率 (%)38.199%39.312%43.121%47.093%46.085%
未計利息、稅項、折舊及攤銷前利潤率 (%)35.389%38.032%69.776%72.384%43.454%
稅前邊際利潤率 (%)33.724%36.623%70.768%69.551%38.839%
純利率 (%)27.444%28.454%55.224%54.861%30.009%
 
變現能力分析
流動比率 (X)2.740 X2.978 X4.497 X10.220 X1.858 X
速動比率 (X)2.735 X2.972 X4.494 X10.216 X1.857 X
 
財務槓桿分析
總負債 / 總資產比率 (%)17.611%17.363%13.209%8.447%27.044%
總負債 / 股東資金比率 (%)24.810%24.278%17.244%10.199%48.193%
非流動負債 / 股東資金比率 (%)5.166%5.278%3.977%3.146%5.527%
利息盈利率 (倍)21.769 X32.197 X149.113 X44.726 X26.774 X
 
營運效率分析
存貨周轉率日數 (日)1.127 Day(s)0.729 Day(s)0.379 Day(s)0.339 Day(s)0.112 Day(s)
 

Copyright © 2024 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.